The World Health Organization has temporarily suspended the use of anti-malaria drug hydroxychloroquine as part of a global effort in finding solution to the novel corona virus pandemic, globally called COVID-19.
The organisation’s executive board made the decision following a study published in the medical journal on The Lancet on 20th May, 2020 that showed that the drug increased mortality rates among Covid-19 patients.
“The executive group has implemented a temporary suspension of the hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” the head of the WHO Dr Tedros Ghebreyesus told journalists in a virtual press briefing.
Although, hydroxycholoroquine has been touted by US President Donald Trump and other leaders as a possible treatment for COVID-19.
Globally, there have been 5,307,298 confirmed cases of COVID-19, including 342,070 deaths, reported to WHO as at 25 May, 2020.
Leave a Reply